KeyBanc Marvell · MRVL

KeyBanc Lifts Marvell Price Target to $400

1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$400
from $385 (+4%)
Upside
+183%
MRVL at $141 today
KeyBanc and Marvell logos

What the analyst said

KeyBanc analyst John Vinh raised the price target on Marvell (NASDAQ: MRVL) to $400 (from $385) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $141. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $400 target is 33% above the median.

Since the note MRVL has moved −35% (from $218). 12-month window: day 115 of 365, closes on July 14, 2027.

Track record

This callOpen: MRVL has not reached $400 yet. This 12-month target is scored on July 14, 2027.

Firm track recordKeyBanc: 79% of its 24 targets at least a year old were reached within 12 months (#13 of 26 firms). Accuracy ranking →

KeyBanc on Marvell

KeyBanc price targets on Marvell

6 calls from March 6, 2026 to October 7, 2026. The target went from $130 to $400 (+208%). The rating stayed Buy.

KeyBanc targetMRVL share price
  1. October 7, 2026Kept the $400 targetBuy$400
  2. August 28, 2026Kept the $400 targetBuy$400
  3. July 14, 2026 This noteTarget raised from $385 (+4%)Buy$400
  4. June 18, 2026Target raised from $260 (+48%)Buy$385
  5. May 28, 2026Target raised from $130 (+100%)Buy$260
  6. March 6, 2026Earliest call shownBuy$130
Share

Other analysts on Marvell

StoneXBuy Kept rating and price target Nov 3 $375maintained UBSBuy Kept rating and price target Nov 3 $350maintained Wells FargoBuy Cut price target −22%, kept rating Nov 3 $285from $365 RBC CapitalBuy Cut price target −41%, kept rating Nov 3 $250from $425 NeedhamBuy Cut price target −25%, kept rating Nov 3 $300from $400
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.